应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
UTHR 美国联合医疗
未开盘 11-15 16:00:00 EST
363.25
-23.02
-5.96%
盘后
363.25
+0.00
0.00%
18:45 EST
最高
385.19
最低
359.11
成交量
62.00万
今开
385.19
昨收
386.27
日振幅
6.75%
总市值
162.17亿
流通市值
148.66亿
总股本
4,464万
成交额
2.26亿
换手率
1.51%
流通股本
4,093万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
美国联合医疗跌2.45% 股价跌破400美元大关
市场透视 · 11-12
美国联合医疗跌2.45% 股价跌破400美元大关
美国联合医疗涨0.71% 股价突破400美元大关
市场透视 · 11-08
美国联合医疗涨0.71% 股价突破400美元大关
美国联合医疗2024财年第三财季实现净利润3.09亿美元,同比增加15.30%
市场透视 · 11-04
美国联合医疗2024财年第三财季实现净利润3.09亿美元,同比增加15.30%
电动飞机制造商贝塔科技公司新融资逾 3 亿美元
Reuters · 11-01
电动飞机制造商贝塔科技公司新融资逾 3 亿美元
United Therapeutics 公司报告截至 9 月 30 日的季度业绩 - 收益摘要
Reuters · 10-30
United Therapeutics 公司报告截至 9 月 30 日的季度业绩 - 收益摘要
美国联合医疗盘中异动 大幅下挫5.02%报351.68美元
市场透视 · 10-23
美国联合医疗盘中异动 大幅下挫5.02%报351.68美元
美国研究综述-Cardinal Health、Factset、Paylocity Holding
Reuters · 09-23
美国研究综述-Cardinal Health、Factset、Paylocity Holding
ProPicks九月AI选股再平衡报告:买入这些股票?卖出这些股票?
英为财情 · 09-02
ProPicks九月AI选股再平衡报告:买入这些股票?卖出这些股票?
BUZZ-Liquidia挑战竞争对手吸入式药物的监管排他性后业绩下滑
Reuters · 08-22
BUZZ-Liquidia挑战竞争对手吸入式药物的监管排他性后业绩下滑
BUZZ-Liquidia因竞争对手的吸入式药物在监管部门的独家经营权受到挑战而下跌
Reuters · 08-22
BUZZ-Liquidia因竞争对手的吸入式药物在监管部门的独家经营权受到挑战而下跌
更新版 1-Liquidia挑战竞争对手吸入式药物的监管排他性
Reuters · 08-22
更新版 1-Liquidia挑战竞争对手吸入式药物的监管排他性
Liquidia 提起诉讼,质疑竞争对手吸入式药物的监管排他性
Reuters · 08-22
Liquidia 提起诉讼,质疑竞争对手吸入式药物的监管排他性
美国联合医疗盘中异动 股价大涨5.31%报338.05美元
自选股智能写手 · 08-19
美国联合医疗盘中异动 股价大涨5.31%报338.05美元
美国联合医疗2024财年第二财季实现净利润2.78亿美元,同比增加7.34%
自选股智能写手 · 08-05
美国联合医疗2024财年第二财季实现净利润2.78亿美元,同比增加7.34%
异动解读 | 美国联合医疗股价大涨5.3% 市场关注其财务表现
异动解读 · 08-02
异动解读 | 美国联合医疗股价大涨5.3% 市场关注其财务表现
美国联合医疗盘中异动 临近收盘大幅拉升5.10%
自选股智能写手 · 08-02
美国联合医疗盘中异动 临近收盘大幅拉升5.10%
HC Wainwright & Co.:重申United Therapeutics(UTHR.US)评级,由买入调整至买入评级, 目标价由400.
智通财经 · 08-01
HC Wainwright & Co.:重申United Therapeutics(UTHR.US)评级,由买入调整至买入评级, 目标价由400.
异动解读 | 美国联合医疗财报不佳 股价盘中大跌7.41%
异动解读 · 07-31
异动解读 | 美国联合医疗财报不佳 股价盘中大跌7.41%
美国联合医疗盘中异动 早盘股价大跌6.37%报316.05美元
自选股智能写手 · 07-31
美国联合医疗盘中异动 早盘股价大跌6.37%报316.05美元
United Therapeutics 公司报告截至 6 月的季度业绩 - 收益摘要
Reuters · 07-31
United Therapeutics 公司报告截至 6 月的季度业绩 - 收益摘要
加载更多
公司概况
公司名称:
美国联合医疗
所属市场:
NASDAQ
上市日期:
--
主营业务:
United Therapeutics Corporation于1996年成立于特拉华。它是一家生物科技公司,致力于能解决患有慢性病和有生命危险病人未被满足的医疗需求的独特产品的开发和商业化。它的收入主要来源于曲前列尼尔、Tyvaso和他达拉非的销售。他们的市场和销售人员会努力使他们的产品在他们那些被授权的国家买到。这些主要是由他们在美国的专业经销商和其它的国际经销商做的。
发行价格:
--
{"stockData":{"symbol":"UTHR","market":"US","secType":"STK","nameCN":"美国联合医疗","latestPrice":363.25,"timestamp":1731704400000,"preClose":386.27,"halted":0,"volume":619978,"hourTrading":{"tag":"盘后","latestPrice":363.25,"preClose":363.25,"latestTime":"18:45 EST","volume":23585,"amount":8567084.0089,"timestamp":1731714350819},"delay":0,"floatShares":40925465,"shares":44644519,"eps":22.723354,"marketStatus":"未开盘","marketStatusCode":0,"change":-23.02,"latestTime":"11-15 16:00:00 EST","open":385.19,"high":385.19,"low":359.11,"amount":225606261.93244,"amplitude":0.067518,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":22.723354,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1731920400000},"adr":0,"listingDate":929592000000,"adjPreClose":386.27,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":386.97,"preClose":386.27,"latestTime":"08:29 EST","volume":14,"amount":5407.46024,"timestamp":1731677386652},"postHourTrading":{"tag":"盘后","latestPrice":363.25,"preClose":363.25,"latestTime":"18:45 EST","volume":23585,"amount":8567084.0089,"timestamp":1731714350819},"volumeRatio":1.662304302975508,"impliedVol":0.3146,"impliedVolPercentile":0.5238},"requestUrl":"/m/hq/s/UTHR","defaultTab":"news","newsList":[{"id":"2482702756","title":"美国联合医疗跌2.45% 股价跌破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2482702756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482702756?lang=zh_cn&edition=full","pubTime":"2024-11-12 02:10","pubTimestamp":1731348645,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日02时10分,美国联合医疗股票出现波动,股价急速跳水2.45%。截至发稿,该股报399.95美元/股,成交量21.2335万股,换手率0.48%,振幅3.33%。美国联合医疗股票所在的生物技术行业中,整体跌幅为0.69%。美国联合医疗公司简介:United Therapeutics Corp 是一家专门从事肺动脉高压的药物研发的公司。该公司的所有销售额都在美国境内产生。该公司还销售一种儿科肿瘤药物,但其重点仍然集中于研究肺动脉高压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112021045a22d4ad3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112021045a22d4ad3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UTHR","LU1571399168.USD","BK4139","BK4532","LU1699723380.USD"],"gpt_icon":0},{"id":"2481554136","title":"美国联合医疗涨0.71% 股价突破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2481554136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481554136?lang=zh_cn&edition=full","pubTime":"2024-11-08 01:09","pubTimestamp":1730999347,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日01时09分,美国联合医疗股票出现异动,股价快速拉升0.71%。截至发稿,该股报400.31美元/股,成交量7.6907万股,换手率0.17%,振幅1.32%。美国联合医疗股票所在的生物技术行业中,整体涨幅为0.64%。美国联合医疗公司简介:United Therapeutics Corp 是一家专门从事肺动脉高压的药物研发的公司。该公司的所有销售额都在美国境内产生。该公司还销售一种儿科肿瘤药物,但其重点仍然集中于研究肺动脉高压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108010907971a527e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108010907971a527e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1571399168.USD","UTHR","LU1699723380.USD","BK4532","BK4139"],"gpt_icon":0},{"id":"2480836028","title":"美国联合医疗2024财年第三财季实现净利润3.09亿美元,同比增加15.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480836028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480836028?lang=zh_cn&edition=full","pubTime":"2024-11-04 00:00","pubTimestamp":1730649633,"startTime":"0","endTime":"0","summary":"11月4日,美国联合医疗公布财报,公告显示公司2024财年第三财季净利润为3.09亿美元,同比增加15.30%;其中营业收入为7.49亿美元,同比增加22.99%,每股基本收益为6.93美元。从资产负债表来看,美国联合医疗总负债10.22亿美元,其中短期债务4.00亿美元,资产负债比为6.97,流动比率为4.59。机构评级:截至2024年11月4日,当前有12家机构对美国联合医疗目标价做出预测,其中目标均价为395.83美元,其中最低目标价为302.00美元,最高目标价为600.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104000059a211d2b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104000059a211d2b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UTHR"],"gpt_icon":0},{"id":"2480606727","title":"电动飞机制造商贝塔科技公司新融资逾 3 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480606727","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480606727?lang=zh_cn&edition=full","pubTime":"2024-11-01 05:14","pubTimestamp":1730409250,"startTime":"0","endTime":"0","summary":" 10月31日 - 电动航空航天公司贝塔技术公司周四表示,该公司已筹集到超过 3 亿美元的股本资金,以支持其可垂直起降的全电动固定翼飞机和电动VTOL飞机的继续生产。重要原因 随着 Beta 致力于降低碳排放,这笔资金将加速其在航空运输业的发展。数字 这家总部位于佛蒙特州的公司在 C 轮融资中筹集了 3.18 亿美元,使迄今为止的融资总额超过 10 亿美元。Beta 在 2022 年完成了 3.75 亿美元的 B 轮融资,由 TPG 领投,其中包括亚马逊 气候认捐基金的第二笔投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4532","UTHR","LU1571399168.USD","LU1699723380.USD"],"gpt_icon":0},{"id":"2479378791","title":"United Therapeutics 公司报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2479378791","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479378791?lang=zh_cn&edition=full","pubTime":"2024-10-30 23:11","pubTimestamp":1730301100,"startTime":"0","endTime":"0","summary":" * United Therapeutics Corp 公布的截至9月30日的季度调整后每股收益为6.39美元,高于去年同期的每股收益5.38美元。13位分析师对该季度的平均预期为每股收益 6.42 美元。华尔街预期为每股收益 5.41 美元至 7.41 美元。* United Therapeutics Corp公布的本季度每股收益为6.39美元。* 公司报告的季度净收入为 3.091 亿美元。* United Therapeutics Corp本季度股价下跌了1.5%,今年迄今为止上涨了60.4%。华尔街对 United Therapeutics Corp 的 12 个月目标价中位数为 382.06 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1699723380.USD","BK4532","BK4139","LU1571399168.USD","UTHR","LENZ"],"gpt_icon":0},{"id":"2477534229","title":"美国联合医疗盘中异动 大幅下挫5.02%报351.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477534229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477534229?lang=zh_cn&edition=full","pubTime":"2024-10-23 23:05","pubTimestamp":1729695954,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日23时05分,美国联合医疗股票出现异动,股价快速下跌5.02%。截至发稿,该股报351.68美元/股,成交量16.1817万股,换手率0.36%,振幅4.91%。机构评级方面,在所有17家参与评级的机构中,53%的券商给予买入建议,35%的券商给予持有建议,12%的券商给予卖出建议。美国联合医疗股票所在的生物技术行业中,整体跌幅为1.20%。该公司的所有销售额都在美国境内产生。该公司还销售一种儿科肿瘤药物,但其重点仍然集中于研究肺动脉高压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102323055598e3e06a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102323055598e3e06a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4532","UTHR","LU1571399168.USD","LU1699723380.USD"],"gpt_icon":0},{"id":"2469165497","title":"美国研究综述-Cardinal Health、Factset、Paylocity Holding","url":"https://stock-news.laohu8.com/highlight/detail?id=2469165497","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469165497?lang=zh_cn&edition=full","pubTime":"2024-09-23 15:33","pubTimestamp":1727076787,"startTime":"0","endTime":"0","summary":" 路透9月23日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价,其中包括卡地纳健康、Factset 和 Paylocity Holding。要闻 * Cardinal Health Inc :贝尔德将目标价从137美元上调至140美元 * Factset :杰富瑞将目标价从435美元上调至486美元 * Marinus Pharmaceuticals Inc :奥本海默将其评级从 \"跑赢大盘 \"上调至 \"跑赢大盘\"。* Paylocity Holding Corp :TD Cowen将目标价从171美元上调至186美元 * United Rentals Inc :摩根大通将目标价从780美元上调至940美元 以下是路透周一报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","LU0211328371.USD","MLKN","BK4516","LU0477156953.USD","F","URI","LU1201861249.SGD","TNET","BK4112","KVUE","LU1861559042.SGD","CAH","LEN","LU0006061336.USD","GEV","LU0310799852.SGD","BK4567","BK4099","APLS","LU2517655028.SGD","LU0477156797.USD","LU2517655291.USD","BK4566","FDS","CRBP","LU0130103400.USD","LU0980610538.SGD","LU1880398554.USD","LU1093756325.SGD","LU0211331839.USD","LU1861558580.USD","BK4551","PYCR","LU0724618433.USD","LU2264538146.SGD","RBLX","MRNS","UTHR","LU0211327993.USD","PCTY","LU1169590202.USD","LU1201861165.SGD","LU0310800965.SGD","LU2517655374.HKD","IE00BFXG1179.USD","LU1917777945.USD","LU0162691827.USD","GM","CRMT"],"gpt_icon":0},{"id":"2464882560","title":"ProPicks九月AI选股再平衡报告:买入这些股票?卖出这些股票?","url":"https://stock-news.laohu8.com/highlight/detail?id=2464882560","media":"英为财情","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464882560?lang=zh_cn&edition=full","pubTime":"2024-09-02 18:13","pubTimestamp":1725272020,"startTime":"0","endTime":"0","summary":"英为财情Investing.com – 八月,美股跌宕起伏,不再像年初那样轻松惬意, 恐慌指数VIX一度升至四年新高,但好消息是在动荡中,市场对蓝筹股的热情重燃,投资者开始再平衡持仓,且标普500指数距离历史新高就差0.5%的涨幅。AI选股策略ProPicks也成功抓住了市场偏好的变化,ProPicks再度跑赢市场,其中最佳价值股策略傲视群雄,单月回报率达4.8%,巴菲特精选紧随其后,升幅达3.5%,超越标普升3.3%,称霸道指升3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://cn.investing.com/news/pro/article-2440397","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investing_news","symbols":["ON","FIBK","NSSC","ANF","CELH","FTNT","ACMR","CABO","BKR","ADBE","NVR","RNG","UTHR","URBN","ADSK","YETI","LVS","FWONK","MMM","FFIV","LECO","IPG","FOXF","HEI","NVDA","AMR","CVLT","FTDR","DDS","EL","CNXC","IBM","NUE","QCOM","WSM","ABNB","PLAB","SNEX","PCAR","STT","SKYW","HAL","FOXA"],"gpt_icon":1},{"id":"2461434815","title":"BUZZ-Liquidia挑战竞争对手吸入式药物的监管排他性后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2461434815","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461434815?lang=zh_cn&edition=full","pubTime":"2024-08-22 21:56","pubTimestamp":1724335011,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) (更新) 8月22日 - ** Liquidia Corp 股价下跌2.61%,报9.72美元** 该公司称已向美国哥伦比亚特区地方法院提起 (link) 诉讼,对美国食品和药物管理局授予United Therapeutics 竞争对手药物Tyvaso DPI 3年独家经营权的决定提出质疑。** 卫生监管机构周一推迟了对Liquidia公司吸入式药物yutrepia的 (link) 传统批准,只允许暂时批准。** 目前,该药物的最终批准将推迟到 2025 年 5 月 23 日专营权到期之后。** 股价今年以来下跌了约 18","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BUZZ","LU1571399168.USD","BK4007","BK4139","UTHR","LU1699723380.USD","LQDA"],"gpt_icon":0},{"id":"2461243394","title":"BUZZ-Liquidia因竞争对手的吸入式药物在监管部门的独家经营权受到挑战而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2461243394","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461243394?lang=zh_cn&edition=full","pubTime":"2024-08-22 18:41","pubTimestamp":1724323292,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 8月22日 - ** Liquidia公司 股价盘前下跌2.71%,报9.71美元** 该公司称已向美国哥伦比亚特区地方法院提起 (link) 诉讼,质疑FDA授予United Therapeutics 竞争对手药物Tyvaso DPI 3年独家经营权的决定。** 卫生监管机构周一推迟了对Liquidia公司吸入式药物yutrepia的 (link) 传统批准,只允许暂时批准。** 目前,该药的最终批准将推迟到 2025 年 5 月 23 日专营权到期之后。** 截至上一交易日收盘,股价年累计下跌约 17","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","UTHR","LU1571399168.USD","BK4532","BUZZ","BK4139","LQDA","LU1699723380.USD"],"gpt_icon":0},{"id":"2461391527","title":"更新版 1-Liquidia挑战竞争对手吸入式药物的监管排他性","url":"https://stock-news.laohu8.com/highlight/detail?id=2461391527","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461391527?lang=zh_cn&edition=full","pubTime":"2024-08-22 18:22","pubTimestamp":1724322157,"startTime":"0","endTime":"0","summary":" 路透8月22日 - Liquidia Corp 周四表示,它已对美国食品和药物管理局授予United Therapeutics 治疗肺部疾病的吸入式药物三年专营权的决定提出法律挑战。美国食品和药物管理局周一批准了United Therapeutics公司的Tyvaso DPI的监管专营权,从而推迟了Liquidia公司的吸入式药物yutrepia的传统批准时间。Liquidia 向哥伦比亚特区地方法院提起诉讼。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1699723380.USD","BK4007","BK4532","BK4139","LQDA","LU1571399168.USD","UTHR"],"gpt_icon":0},{"id":"2461993383","title":"Liquidia 提起诉讼,质疑竞争对手吸入式药物的监管排他性","url":"https://stock-news.laohu8.com/highlight/detail?id=2461993383","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461993383?lang=zh_cn&edition=full","pubTime":"2024-08-22 18:06","pubTimestamp":1724321205,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透8月22日 - Liquidia Corp 周四表示,该公司已向美国哥伦比亚特区地方法院提起诉讼,对美国食品和药物管理局最近决定授予United Therapeutics的 治疗一种肺部疾病的吸入式药物三年独家经营权一事提出质疑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UTHR","BK4139","LU1571399168.USD","BK4007","BK4532","LQDA","LU1699723380.USD"],"gpt_icon":0},{"id":"2460303453","title":"美国联合医疗盘中异动 股价大涨5.31%报338.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460303453","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460303453?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:35","pubTimestamp":1724074546,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时35分,美国联合医疗股票出现异动,股价急速拉升5.31%。截至发稿,该股报338.05美元/股,成交量4.6948万股,换手率0.11%,振幅2.80%。美国联合医疗股票所在的生物技术行业中,整体涨幅为0.24%。肺动脉高压是一种罕见的进行性疾病,其特征为肺动脉血压异常升高。该公司的所有销售额都在美国境内产生。该公司还销售一种儿科肿瘤药物,但其重点仍然集中于研究肺动脉高压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921354698e35579&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921354698e35579&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1699723380.USD","BK4532","LU1571399168.USD","UTHR"],"gpt_icon":0},{"id":"2457758476","title":"美国联合医疗2024财年第二财季实现净利润2.78亿美元,同比增加7.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457758476","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457758476?lang=zh_cn&edition=full","pubTime":"2024-08-05 00:14","pubTimestamp":1722788072,"startTime":"0","endTime":"0","summary":"8月5日,美国联合医疗公布财报,公告显示公司2024财年第二财季净利润为2.78亿美元,同比增加7.34%;其中营业收入为7.15亿美元,同比增加19.77%,每股基本收益为6.26美元。从资产负债表来看,美国联合医疗总负债10.26亿美元,其中短期债务4.00亿美元,资产负债比为6.56,流动比率为4.36。机构评级:截至2024年8月5日,当前有11家机构对美国联合医疗目标价做出预测,其中目标均价为341.00美元,其中最低目标价为240.00美元,最高目标价为400.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408050014409f0dcf09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408050014409f0dcf09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UTHR"],"gpt_icon":0},{"id":"1164209283","title":"异动解读 | 美国联合医疗股价大涨5.3% 市场关注其财务表现","url":"https://stock-news.laohu8.com/highlight/detail?id=1164209283","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164209283?lang=zh_cn&edition=full","pubTime":"2024-08-02 03:56","pubTimestamp":1722542178,"startTime":"0","endTime":"0","summary":"美国联合医疗(UTHR)股价今日盘中大涨5.3%,引发市场广泛关注。该公司是一家专注于研发治疗肺动脉高压药物的生物技术公司。\n\n根据最新财报数据,美国联合医疗实现营业收入6.78亿美元,净利润3.07亿美元,每股收益6.52美元,毛利6.05亿美元,市盈率为15.11倍。财务表现较为出色,可能是推动股价上涨的主要原因之一。\n\n此外,机构评级方面,有50%的分析师给予该股买入评级,38%的分析师给予持有评级,反映出机构对该公司前景的乐观预期。但也有12%的分析师给予卖出评级,显示市场对该股存在一定分歧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UTHR"],"gpt_icon":0},{"id":"2456466895","title":"美国联合医疗盘中异动 临近收盘大幅拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456466895","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456466895?lang=zh_cn&edition=full","pubTime":"2024-08-02 03:36","pubTimestamp":1722540967,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日03时36分,美国联合医疗股票出现异动,股价大幅拉升5.10%。截至发稿,该股报329.27美元/股,成交量41.1323万股,换手率0.92%,振幅5.37%。美国联合医疗股票所在的生物技术行业中,整体涨幅为0.60%。肺动脉高压是一种罕见的进行性疾病,其特征为肺动脉血压异常升高。该公司的所有销售额都在美国境内产生。该公司还销售一种儿科肿瘤药物,但其重点仍然集中于研究肺动脉高压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802033607aefcbc20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802033607aefcbc20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","BK4139","LU1571399168.USD","LU1699723380.USD","UTHR"],"gpt_icon":1},{"id":"2456548775","title":"HC Wainwright & Co.:重申United Therapeutics(UTHR.US)评级,由买入调整至买入评级, 目标价由400.","url":"https://stock-news.laohu8.com/highlight/detail?id=2456548775","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456548775?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:08","pubTimestamp":1722517694,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4532","BK4139","LU1571399168.USD","LU1699723380.USD","UTHR"],"gpt_icon":0},{"id":"1191541599","title":"异动解读 | 美国联合医疗财报不佳 股价盘中大跌7.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191541599","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191541599?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:44","pubTimestamp":1722433492,"startTime":"0","endTime":"0","summary":"美国生物制药公司美国联合医疗(United Therapeutics Corp.,股票代码UTHR)今日盘中股价大跌7.41%,引发市场广泛关注。\n\n公司此前公布的2024年第二季度财报显示,调整后每股收益为5.85美元,低于分析师平均预期的6.4美元。虽然营收同比增长19.8%至7.149亿美元,高于预期,但净利润仅为2.781亿美元,未能达到市场预期。\n\n分析人士指出,美国联合医疗本季度业绩不佳主要源于研发投入加大以及销售费用上升所致。公司正在加速新药研发进程,以期在未来几年内推出更多创新产品,但短期内将继续面临较高的成本压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UTHR"],"gpt_icon":0},{"id":"2455134479","title":"美国联合医疗盘中异动 早盘股价大跌6.37%报316.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455134479","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455134479?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:34","pubTimestamp":1722432846,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日21时34分,美国联合医疗股票出现波动,股价快速下跌6.37%。截至发稿,该股报316.05美元/股,成交量5.5825万股,换手率0.13%,振幅3.12%。最近的财报数据显示,该股实现营业收入6.78亿美元,净利润3.07亿美元,每股收益6.52美元,毛利6.05亿美元,市盈率14.96倍。美国联合医疗股票所在的生物技术行业中,整体涨幅为0.51%。该公司的所有销售额都在美国境内产生。该公司还销售一种儿科肿瘤药物,但其重点仍然集中于研究肺动脉高压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407312134069f022efb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407312134069f022efb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","LU1699723380.USD","LU1571399168.USD","BK4139","UTHR"],"gpt_icon":0},{"id":"2455139076","title":"United Therapeutics 公司报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2455139076","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455139076?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:32","pubTimestamp":1722432751,"startTime":"0","endTime":"0","summary":" * United Therapeutics Corp 公布的截至6月底的季度调整后每股收益为5.85美元,高于去年同期的每股收益5.24美元。12 位分析师对该季度的平均预期为每股收益 6.40 美元。华尔街预期为每股收益 5.59 美元至 7.47 美元。* United Therapeutics 公司公布的本季度每股收益为 5.85 美元。* 公司报告的季度净收入为 2.781 亿美元。* United Therapeutics Corp本季度股价上涨了6.0%,今年迄今为止上涨了53.5%。华尔街对 United Therapeutics Corp 的 12 个月目标价中位数为 347.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UTHR","LU1571399168.USD","BK4139","LENZ","BK4532","LU1699723380.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.unither.com","stockEarnings":[{"period":"1week","weight":-0.114},{"period":"1month","weight":-0.0181},{"period":"3month","weight":0.1317},{"period":"6month","weight":0.3245},{"period":"1year","weight":0.6028},{"period":"ytd","weight":0.652}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"United Therapeutics Corporation于1996年成立于特拉华。它是一家生物科技公司,致力于能解决患有慢性病和有生命危险病人未被满足的医疗需求的独特产品的开发和商业化。它的收入主要来源于曲前列尼尔、Tyvaso和他达拉非的销售。他们的市场和销售人员会努力使他们的产品在他们那些被授权的国家买到。这些主要是由他们在美国的专业经销商和其它的国际经销商做的。","yearOnYearQuotes":[{"month":1,"riseRate":0.48,"avgChangeRate":0.00747},{"month":2,"riseRate":0.52,"avgChangeRate":0.024094},{"month":3,"riseRate":0.48,"avgChangeRate":0.009128},{"month":4,"riseRate":0.44,"avgChangeRate":-0.021662},{"month":5,"riseRate":0.56,"avgChangeRate":0.049766},{"month":6,"riseRate":0.56,"avgChangeRate":0.034002},{"month":7,"riseRate":0.615385,"avgChangeRate":0.04733},{"month":8,"riseRate":0.5,"avgChangeRate":0.049875},{"month":9,"riseRate":0.423077,"avgChangeRate":0.042994},{"month":10,"riseRate":0.615385,"avgChangeRate":-0.005689},{"month":11,"riseRate":0.615385,"avgChangeRate":0.053398},{"month":12,"riseRate":0.6,"avgChangeRate":0.03414}],"exchange":"NASDAQ","name":"美国联合医疗","nameEN":"United Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美国联合医疗(UTHR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美国联合医疗(UTHR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美国联合医疗,UTHR,美国联合医疗股票,美国联合医疗股票老虎,美国联合医疗股票老虎国际,美国联合医疗行情,美国联合医疗股票行情,美国联合医疗股价,美国联合医疗股市,美国联合医疗股票价格,美国联合医疗股票交易,美国联合医疗股票购买,美国联合医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美国联合医疗(UTHR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美国联合医疗(UTHR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}